Delivery Order SPE2DB22D1041-SPE2DB25FTZT0

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,837.76 for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a specialty pharmaceutical product, with a ceiling value of $39,136.27. The contract has a firm fixed price and is set to be completed by September 17, 2024. Amerisourcebergen Drug Corp is a for-profit pharmaceutical distribution and healthcare solutions...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,385.97, is for the supply of Vivitrol 380 mg vials and diluents. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The $2,837.76 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, on December 20, 2024, with a completion date of December 23, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The delivery order is valued at $2,642.05 and has a completion date of June 12, 2024. It is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vivitrol 380 mg vials and diluents. The contract has a ceiling value of $1,755.72 and runs through February 17, 2023. This is a firm fixed-price contract, and there is no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract, valued at $3,572.06, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.17 firm fixed-price delivery order is for VIVITROL 380 MG VIAL-DILUENTS and has a completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,471.91, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid dependence and alcohol dependence. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. The contract has an...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,742.93 and is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract is a firm fixed price agreement with an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB25FTZT0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a firm fixed price of $8,579.09 and an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated as a set-aside contract.

Generated 5/30/25, 10:03 AM